The Clinical Diagnostic and Prognostic Value of Dickkopf-1 in Cancer

References

• Niehrs C. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene. 2006;25(57):7469–7481. doi:10.1038/sj.onc.121005417143291
   PubMed Web of Science ®Google Scholar
• Fedi P, Bafico A, Nieto Soria A, et al. Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling. J Biol Chem. 1999;274(27):19465–19472. doi:10.1074/jbc.274.27.1946510383463
   PubMed Web of Science ®Google Scholar
• Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature. 1998;391(6665):357–362. doi:10.1038/348489450748
   PubMed Web of Science ®Google Scholar
• Cappuccio I, Calderone A, Busceti CL, et al. Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is required for the development of ischemic neuronal death. J Neurosci. 2005;25(10):2647–2657. doi:10.1523/JNEUROSCI.5230-04.200515758175
   PubMed Web of Science ®Google Scholar
• Caricasole A, Copani A, Caraci F, et al. Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer’s brain. J Neurosci. 2004;24(26):6021–6027. doi:10.1523/JNEUROSCI.1381-04.200415229249
   PubMed Web of Science ®Google Scholar
• Carter M, Chen X, Slowinska B, et al. Crooked tail (Cd) model of human folate-responsive neural tube defects is mutated in Wnt coreceptor lipoprotein receptor-related protein 6. Proc Natl Acad Sci U S A. 2005;102(36):12843–12848. doi:10.1073/pnas.050196310216126904
   PubMed Web of Science ®Google Scholar
• Gregory CA, Gunn WG, Reyes E, et al. How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow. Ann N Y Acad Sci. 2005;1049(1):97–106. doi:10.1196/annals.1334.01015965110
   PubMedGoogle Scholar
• Gunn WG, Conley A, Deininger L, Olson SD, Prockop DJ, Gregory CA. A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma. Stem Cells. 2006;24(4):986–991. doi:10.1634/stemcells.2005-022016293576
   PubMed Web of Science ®Google Scholar
• Tian E, Zhan F, Walker R, et al. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med. 2003;349(26):2483–2494. doi:10.1056/NEJMoa03084714695408
   PubMed Web of Science ®Google Scholar
• Mazon M, Larouche V, St-Louis M, Schindler D, Carreau M. Elevated blood levels of Dickkopf-1 are associated with acute infections. Immun Inflamm Dis. 2018;6(4):428–434. doi:10.1002/iid3.23230028084
   PubMed Web of Science ®Google Scholar
• Rani S, Chauhan R, Parsad D, Kumar R. Effect of Dickkopf1 on the senescence of melanocytes: in vitro study. Arch Dermatol Res. 2018;310(4):343–350. doi:10.1007/s00403-018-1820-129442138
   PubMed Web of Science ®Google Scholar
• Ross RD, Shah RC, Leurgans S, Bottiglieri T, Wilson RS, Sumner DR. Circulating Dkk1 and TRAIL are associated with cognitive decline in community-dwelling, older adults with cognitive concerns. J Gerontol a Biol Sci Med Sci. 2018;73(12):1688–1694. doi:10.1093/gerona/glx252
   PubMed Web of Science ®Google Scholar
• Yu C, Seaton M, Letendre S, Heaton R, Al-Harthi L. Plasma dickkopf-related protein 1, an antagonist of the Wnt pathway, is associated with HIV-associated neurocognitive impairment. AIDS. 2017;31(10):1379–1385. doi:10.1097/QAD.000000000000148128358733
   PubMed Web of Science ®Google Scholar
• Dong LL, Qu LY, Chu LY, Zhang XH, Liu YH. Serum level of DKK-1 and its prognostic potential in non-small cell lung cancer. Diagn Pathol. 2014;9(1):52. doi:10.1186/1746-1596-9-5224612589
   PubMedGoogle Scholar
• Feng Y, Zhang Y, Wei X, Zhang Q. Correlations of DKK1 with pathogenesis and prognosis of human multiple myeloma. Cancer Biomarkers Sect a Dis Markers. 2019;24(2):195–201. doi:10.3233/CBM-181909
   PubMed Web of Science ®Google Scholar
• Jiang T, Huang L, Zhang S. DKK-1 in serum as a clinical and prognostic factor in patients with cervical cancer. Int J Biol Markers. 2013;28(2):221–225. doi:10.5301/jbm.500000523595579
   PubMed Web of Science ®Google Scholar
• Kasoha M, Bohle RM, Seibold A, Gerlinger C, Juhasz-Böss I, Solomayer EF. Dickkopf-1 (Dkk1) protein expression in breast cancer with special reference to bone metastases. Clin Exp Metastasis. 2018;35(8):763–775. doi:10.1007/s10585-018-9937-330238177
   PubMed Web of Science ®Google Scholar
• Kim SU, Park JH, Kim HS, et al. Serum Dickkopf-1 as a biomarker for the diagnosis of hepatocellular carcinoma. Yonsei Med J. 2015;56(5):1296–1306. doi:10.3349/ymj.2015.56.5.129626256972
   PubMed Web of Science ®Google Scholar
• Sheng SL, Huang G, Yu B, Qin WX. Clinical significance and prognostic value of serum Dickkopf-1 concentrations in patients with lung cancer. Clin Chem. 2009;55(9):1656–1664. doi:10.1373/clinchem.2009.12564119628661
   PubMed Web of Science ®Google Scholar
• Sun DK, Wang L, Wang JM, Zhang P. Serum Dickkopf-1 levels as a clinical and prognostic factor in patients with bladder cancer. Genet Mol Res GMR. 2015;14(4):18181–18187. doi:10.4238/2015.December.23.526782465
   PubMed Web of Science ®Google Scholar
• Aufderklamm S, Hennenlotter J, Leidenberger P, et al. Systemic alterations of Wnt inhibitors in patients with prostate cancer and bone metastases. Dis Markers. 2018;2018:1874598. doi:10.1155/2018/187459830116403
   PubMed Web of Science ®Google Scholar
• González-Sancho JM, Aguilera O, García JM, et al. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene. 2005;24(6):1098–1103. doi:10.1038/sj.onc.120830315592505
   PubMed Web of Science ®Google Scholar
• Gao Y, Du X, Zeng J, et al. Prediction and identification of transcriptional regulatory elements at the lung cancer-specific DKK1 locus. Oncol Lett. 2018;16(1):137–144. doi:10.3892/ol.2018.863829928394
   PubMed Web of Science ®Google Scholar
• Tang Y, Zhang Z, Tang Y, Chen X, Zhou J. Identification of potential target genes in pancreatic ductal adenocarcinoma by bioinformatics analysis. Oncol Lett. 2018;16(2):2453–2461. doi:10.3892/ol.2018.891230013637
   PubMed Web of Science ®Google Scholar
• Zhou X-L, Qin X-R, Zhang X-D, Ye L-H. Downregulation of Dickkopf-1 is responsible for high proliferation of breast cancer cells via losing control of Wnt/beta-catenin signaling. Acta Pharmacol Sin. 2010;31(2):202–210. doi:10.1038/aps.2009.20020139903
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang S. Dickkopf-1 is frequently overexpressed in ovarian serous carcinoma and involved in tumor invasion. Clin Exp Metastasis. 2011;28(6):581–591. doi:10.1007/s10585-011-9393-921607803
   PubMed Web of Science ®Google Scholar
• Takahashi N, Fukushima T, Yorita K, Tanaka H, Chijiiwa K, Kataoka H. Dickkopf-1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involved in invasive growth. Int J Cancer. 2010;126(7):1611–1620. doi:10.1002/ijc.2486519711349
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang J, Chen Z, Wang K, Shi L. MicroRNA-1-3p inhibits the proliferation and migration of oral squamous cell carcinoma cells by targeting DKK1. Biochem Cell Biol. 2018;96(3):355–364. doi:10.1139/bcb-2017-001528763625
   PubMedGoogle Scholar
• Shi X-D, Yu X-H, Wu W-R, et al. Dickkopf-1 expression is associated with tumorigenity and lymphatic metastasis in human hilar cholangiocarcinoma. Oncotarget. 2016;7(43):70378–70387. doi:10.18632/oncotarget.1185927608843
   PubMedGoogle Scholar
• Li S, Qin X, Guo X, et al. Dickkopf-1 is oncogenic and involved in invasive growth in non small cell lung cancer. PLoS One. 2013;8(12):e84944–e84944. doi:10.1371/journal.pone.008494424391982
   PubMed Web of Science ®Google Scholar
• Agur Z, Kirnasovsky OU, Vasserman G, et al. Dickkopf1 regulates fate decision and drives breast cancer stem cells to differentiation: an experimentally supported mathematical model. PLoS One. 2011;6(9):e24225–e24225. doi:10.1371/journal.pone.002422521915302
   PubMed Web of Science ®Google Scholar
• Mikheev AM, Mikheeva SA, Maxwell J-P, et al. Dickkopf-1 mediated tumor suppression in human breast carcinoma cells. Breast Cancer Res Treat. 2008;112(2):263–273. doi:10.1007/s10549-007-9867-218157634
   PubMed Web of Science ®Google Scholar
• Mariz K, Ingolf J-B, Daniel H, Teresa NJ, Erich-Franz S. The Wnt inhibitor dickkopf-1: a link between breast cancer and bone metastases. Clin Exp Metastasis. 2015;32(8):857–866. doi:10.1007/s10585-015-9750-126420587
   PubMed Web of Science ®Google Scholar
• Pinzone JJ, Hall BM, Thudi NK, et al. The role of Dickkopf-1 in bone development, homeostasis, and disease. Blood. 2009;113(3):517–525. doi:10.1182/blood-2008-03-14516918687985
   PubMed Web of Science ®Google Scholar
• Lang J, Zhao Q, He Y, Yu X. Bone turnover markers and novel biomarkers in lung cancer bone metastases. Biomarkers. 2018;23(6):518–526. doi:10.1080/1354750X.2018.146356629683727
   PubMed Web of Science ®Google Scholar
• Qiao R, Zhong R, Chang Q, et al. Serum dickkopf-1 as a clinical and prognostic factor in non-small cell lung cancer patients with bone metastases. Oncotarget. 2017;8(45):79469–79479. doi:10.18632/oncotarget.1844629108326
   PubMedGoogle Scholar
• Fouad YM, Mohamed HI, Kamal EM, Rasek MA. Clinical significance and diagnostic value of serum dickkopf-1 in patients with hepatocellular carcinoma. Scand J Gastroenterol. 2016;51(9):1133–1137. doi:10.3109/00365521.2016.117233727161933
   PubMed Web of Science ®Google Scholar
• Shen Q, Fan J, Yang XR, et al. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. Lancet Oncol. 2012;13(8):817–826. doi:10.1016/S1470-2045(12)70233-422738799
   PubMed Web of Science ®Google Scholar
• Igbinigie E, Guo F, Jiang SW, Kelley C, Li J. Dkk1 involvement and its potential as a biomarker in pancreatic ductal adenocarcinoma. Clin Chim Acta. 2019;488:226–234. doi:10.1016/j.cca.2018.11.02330452897
   PubMed Web of Science ®Google Scholar
• Shizhuo W, Tao J, Shulan Z, Bing Z. The expression and significance of Dickkopf-1 in epithelial ovarian carcinoma. Int J Biol Markers. 2009;24(3):165–170. doi:10.1177/17246008090240030619787627
   PubMed Web of Science ®Google Scholar
• Han S-X, Zhou X, Sui X, et al. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer. Oncotarget. 2015;6(23):19907–19917. doi:10.18632/oncotarget.452926101916
   PubMed Web of Science ®Google Scholar
• Yao X, Jiang H, Zhang C, et al. Dickkopf-1 autoantibody is a novel serological biomarker for non-small cell lung cancer. Biomarkers. 2010;15(2):128–134. doi:10.3109/1354750090332566219839718
   PubMed Web of Science ®Google Scholar
• Peng Y-H, Xu Y-W, Guo H, et al. Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma. Cancer Med. 2016;5(7):1388–1396. doi:10.1002/cam4.70226988995
   PubMed Web of Science ®Google Scholar
• Shen L, Wu X, Tan J, et al. Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancer. Onco Targets Ther. 2017;10:3545–3556. doi:10.2147/OTT.S13416228790847
   PubMed Web of Science ®Google Scholar
• Liu D-J, Xie Y-X, Liu -X-X, et al. The role of Dickkopf-1 as a potential prognostic marker in pancreatic ductal adenocarcinoma. Cell Cycle. 2017;16(17):1622–1629. doi:10.1080/15384101.2017.135651028749252
   PubMed Web of Science ®Google Scholar
• Kandimalla R, Linnekamp JF, van Hooff S, et al. Methylation of WNT target genes AXIN2 and DKK1 as robust biomarkers for recurrence prediction in stage II colon cancer. Oncogenesis. 2017;6(4):e308–e308. doi:10.1038/oncsis.2017.928368388
   PubMedGoogle Scholar
• Désert R, Mebarki S, Desille M, et al. “Fibrous nests” in human hepatocellular carcinoma express a Wnt-induced gene signature associated with poor clinical outcome. Int J Biochem Cell Biol. 2016;81(Pt A):195–207. doi:10.1016/j.biocel.2016.08.01727545991
   PubMedGoogle Scholar
• Koromila T, Georgoulias P, Dailiana Z, et al. CER1 gene variations associated with bone mineral density, bone markers, and early menopause in postmenopausal women. Hum Genomics. 2013;7(1):21. doi:10.1186/1479-7364-7-2124138842
   PubMedGoogle Scholar
• Bao GY, Lu KY, Cui SF, Xu L. DKK1 eukaryotic expression plasmid and expression product identification. Genet Mol Res. 2015;14(2):6312–6318. doi:10.4238/2015.June.11.526125834
   PubMed Web of Science ®Google Scholar
• Reuschenbach M, von Knebel Doeberitz M, Wentzensen N. A systematic review of humoral immune responses against tumor antigens. Cancer Immunol Immunother. 2009;58(10):1535–1544. doi:10.1007/s00262-009-0733-419562338
   PubMed Web of Science ®Google Scholar
• Lu H, Goodell V, Disis ML. Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer. J Proteome Res. 2008;7(4):1388–1394. doi:10.1021/pr700818f18311901
   PubMed Web of Science ®Google Scholar
• Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. 2013;19(2):179–192. doi:10.1038/nm.307423389618
   PubMed Web of Science ®Google Scholar
• Park BM, Kim EJ, Nam HJ, et al. Cyclized oligopeptide targeting LRP5/6-DKK1 interaction reduces the growth of tumor burden in a multiple myeloma mouse model. Yonsei Med J. 2017;58(3):505–513. doi:10.3349/ymj.2017.58.3.50528332354
   PubMed Web of Science ®Google Scholar
• Liu -T-T, Wu Y, Human NT. DKK1 and human HSP70 fusion DNA vaccine induces an effective anti-tumor efficacy in murine multiple myeloma. Oncotarget. 2017;9(1):178–191. doi:10.18632/oncotarget.2335229416605
   PubMedGoogle Scholar
• Florio M, Gunasekaran K, Stolina M, et al. A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair. Nat Commun. 2016;7(1):11505. doi:10.1038/ncomms1150527230681
   PubMedGoogle Scholar
• Iyer SP, Beck JT, Stewart AK, et al. A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events. Br J Haematol. 2014;167(3):366–375. doi:10.1111/bjh.1305625139740
   PubMed Web of Science ®Google Scholar
• Sato N, Yamabuki T, Takano A, et al. Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy. Cancer Res. 2010;70(13):5326–5336. doi:10.1158/0008-5472.CAN-09-387920551066
   PubMed Web of Science ®Google Scholar
• Wang C, Liao H, Sun H, Zhang Y, Cao Z. MicroRNA-3064-3p regulates the differentiation of cementoblasts through targeting DKK1. J Periodontal Res. 2018;53(5):705–713. doi:10.1111/jre.1255429704238
   PubMed Web of Science ®Google Scholar
• Zhao X, Sun S, Xu J, Luo Y, Xin Y, Wang Y. MicroRNA-152 inhibits cell proliferation of osteosarcoma by directly targeting Wnt/β-catenin signaling pathway in a DKK1-dependent manner. Oncol Rep. 2018;40(2):767–774. doi:10.3892/or.2018.645629845282
   PubMed Web of Science ®Google Scholar